Stock 2509 QYUNS THERAPEUTICS CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

All News Qyuns Therapeutics Co., Ltd.

Equities

2509

CNE1000069W9

Market Closed - Hong Kong S.E.
Other stock markets
 09:08:08 27/06/2024 BST 		5-day change 1st Jan Change
22.05 HKD -19.08% Intraday chart for Qyuns Therapeutics Co., Ltd. -23.17% 0.00%
06-17 Qyuns Therapeutics Releases Data from Phase 2 Trial for Prurigo Nodularis Drug MT
05-30 Qyuns Therapeutics Enrolls First Subject in Phase 3 Trial of Skin Disease Drug MT

All News

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Qyuns Therapeutics Releases Data from Phase 2 Trial for Prurigo Nodularis Drug
MT
Qyuns Therapeutics Enrolls First Subject in Phase 3 Trial of Skin Disease Drug
MT
Qyuns Therapeutics Co., Ltd. Announces First Subject Enrollment for QX005N Phase III Clinical Trial for the Treatment of Prurigonodularis
CI
China Grants Investigational New Drug Status to Qyuns Therapeutics' Urticaria Treatment
MT
Qyuns Therapeutics Co., Ltd. Obtains IND Clearance for QX013N for Treatment of Chronic Spontane Urticaria in China
CI
Hansoh Healthtech Company Limited Enters into License Agreement with Qyuns Therapeutics Co., Ltd
CI
Qyuns Therapeutics Co., Ltd. Enters into an Exclusive Outlicensing Agreement with Hansoh Healthtech Co., Ltd
CI
Hong Kong Shares Inch Up After China Holds Benchmark Rates Steady; Qyuns Therapeutics Falls 9% on Debut
MT
Qyuns Therapeutics Opens 38% Higher in Hong Kong Trading Debut
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 2509 Stock
  4. News Qyuns Therapeutics Co., Ltd.